These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Therapeutic angiogenesis in cardiovascular disease. Al Sabti H J Cardiothorac Surg; 2007 Nov; 2():49. PubMed ID: 18021404 [TBL] [Abstract][Full Text] [Related]
26. [Arteriogenesis: a new strategy of therapeutic intervention in chronic arterial disorders. Cellular mechanism and experimental models]. Erdo F; Buschmann IR Orv Hetil; 2007 Apr; 148(14):633-42. PubMed ID: 17403636 [TBL] [Abstract][Full Text] [Related]
27. Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation. van Weel V; van Tongeren RB; van Hinsbergh VW; van Bockel JH; Quax PH Ann Vasc Surg; 2008; 22(4):582-97. PubMed ID: 18504100 [TBL] [Abstract][Full Text] [Related]
28. A computational analysis of pro-angiogenic therapies for peripheral artery disease. Clegg LE; Mac Gabhann F Integr Biol (Camb); 2018 Jan; 10(1):18-33. PubMed ID: 29327758 [TBL] [Abstract][Full Text] [Related]
30. Therapeutic neovascularization for peripheral arterial diseases: advances and perspectives. Zhou B; Poon MC; Pu WT; Han ZC Histol Histopathol; 2007 Jun; 22(6):677-86. PubMed ID: 17357097 [TBL] [Abstract][Full Text] [Related]
31. Changing the logic of therapeutic angiogenesis for ischemic disease. Emanueli C; Madeddu P Trends Mol Med; 2005 May; 11(5):207-16. PubMed ID: 15882608 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic angiogenesis of adipose-derived stem cells for ischemic diseases. Zhao L; Johnson T; Liu D Stem Cell Res Ther; 2017 Jun; 8(1):125. PubMed ID: 28583178 [TBL] [Abstract][Full Text] [Related]
33. Approaches to therapeutic angiogenesis for ischemic heart disease. Johnson T; Zhao L; Manuel G; Taylor H; Liu D J Mol Med (Berl); 2019 Feb; 97(2):141-151. PubMed ID: 30554258 [TBL] [Abstract][Full Text] [Related]
34. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation? Lekas M; Lekas P; Latter DA; Kutryk MB; Stewart DJ Curr Opin Cardiol; 2006 Jul; 21(4):376-84. PubMed ID: 16755208 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic angiogenesis for revascularization in peripheral artery disease. Grochot-Przeczek A; Dulak J; Jozkowicz A Gene; 2013 Aug; 525(2):220-8. PubMed ID: 23566831 [TBL] [Abstract][Full Text] [Related]
36. Cellular and molecular therapeutic modalities for arterial obstructive syndromes. Staudacher DL; Preis M; Lewis BS; Grossman PM; Flugelman MY Pharmacol Ther; 2006 Jan; 109(1-2):263-73. PubMed ID: 16243400 [TBL] [Abstract][Full Text] [Related]
37. Angiogenic Growth Factors for Coronary Artery Disease: Current Status and Prospects. Guo M; Shi JH; Wang PL; Shi DZ J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):130-141. PubMed ID: 29025278 [TBL] [Abstract][Full Text] [Related]
38. Therapeutic angiogenesis using vascular endothelial growth factor. Ye L; Haider HK; Jiang SJ; Sim EK Asian Cardiovasc Thorac Ann; 2004 Jun; 12(2):173-81. PubMed ID: 15213090 [TBL] [Abstract][Full Text] [Related]
39. Angiogenesis and the heart. Sharma SG; Nanda S; Longo S Recent Pat Cardiovasc Drug Discov; 2010 Nov; 5(3):171-6. PubMed ID: 20874672 [TBL] [Abstract][Full Text] [Related]
40. [The molecular bypass: an established method for revascularisation of non-operable PAD patients or merely a future vision]. Herold J; Said S; Braun-Dullaeus R Zentralbl Chir; 2014 Oct; 139(5):508-17. PubMed ID: 24089345 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]